glp-1 drugs trump The Administration is delivering big news in Medicare! Through the Medicare Bridge, eligible beneficiaries can access certain GLP-1 medications for weight management for just a $50 monthly copay. It's a President Donald Trump announced Thursday
Description
This is a worthy read to give a comprehensive presentation as to the risks/benefits as well as the need for vigilance.
22, 2025, when the U.S Food and Drug Administration (FDA) approved oral Wegovy by Novo Nordisk as the first daily, oral GLP-1 pill for weight management.
When these drugs activate those receptors, they appear to: Reduce neuroinflammation Improve the brain's ability to clear amyloid and tau Protect connections between neurons Improve brain insulin sensitivity Before you run to your doctor: The nuance matters here
A commission may be earned if you purchase through links in this article
To provide you with control and support all day.
